158 related articles for article (PubMed ID: 23421471)
1. Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer.
Moss EL; Moran A; Reynolds TM; Stokes-Lampard H
BMC Womens Health; 2013 Feb; 13():8. PubMed ID: 23421471
[TBL] [Abstract][Full Text] [Related]
2. The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey.
Moss EL; Hollingworth J; Holland M; Murphy DJ; Fernando I; Reynolds TM
Int J Gynecol Cancer; 2008; 18(3):439-45. PubMed ID: 17692086
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study.
Funston G; Hamilton W; Abel G; Crosbie EJ; Rous B; Walter FM
PLoS Med; 2020 Oct; 17(10):e1003295. PubMed ID: 33112854
[TBL] [Abstract][Full Text] [Related]
4. Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.
Pitta Dda R; Sarian LO; Barreta A; Campos EA; Andrade LL; Fachini AM; Campbell LM; Derchain S
BMC Cancer; 2013 Sep; 13():423. PubMed ID: 24044637
[TBL] [Abstract][Full Text] [Related]
5. Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines.
Crawford SM; Evans C
Fam Pract; 2018 Mar; 35(2):199-202. PubMed ID: 29029123
[TBL] [Abstract][Full Text] [Related]
6. Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology.
Jones OT; Jurascheck LC; Utukuri M; Pannebakker MM; Emery J; Walter FM
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1706-1712. PubMed ID: 30977937
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
8. The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory.
Sturgeon CM; Duffy MJ; Walker G
Ann Clin Biochem; 2011 Jul; 48(Pt 4):295-9. PubMed ID: 21746796
[TBL] [Abstract][Full Text] [Related]
9. General practitioner referral patterns for women with gynaecological symptoms: a randomised incomplete block study design.
Ramanathan SA; Baratiny G; Stocks NP; Searles AM; Redford RJ
Med J Aust; 2011 Nov; 195(10):602-6. PubMed ID: 22107011
[TBL] [Abstract][Full Text] [Related]
10. The interface with naturopathy in rural primary health care: a survey of referral practices of general practitioners in rural and regional New South Wales, Australia.
Wardle JL; Sibbritt DW; Adams J
BMC Complement Altern Med; 2014 Jul; 14():238. PubMed ID: 25015794
[TBL] [Abstract][Full Text] [Related]
11. The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach.
van Gils T; Senler TG; van der Horst HE; Mulder CJJ; Bouma G; de Vries H
Eur J Gen Pract; 2018 Dec; 24(1):236-242. PubMed ID: 30277085
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
Cho HY; Park SH; Park YH; Kim HB; Kang JB; Hong SH; Kyung MS
J Korean Med Sci; 2015 Dec; 30(12):1777-83. PubMed ID: 26713052
[TBL] [Abstract][Full Text] [Related]
13. Sickness certification in primary care: a survey on views and practices among Swiss physicians.
Kedzia S; Kunz R; Zeller A; Rosemann T; Frey P; Sommer J; Herzig L; Alexanderson K; de Boer WE
Swiss Med Wkly; 2015; 145():w14201. PubMed ID: 26588114
[TBL] [Abstract][Full Text] [Related]
14. Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
Sölétormos G; Duffy MJ; Othman Abu Hassan S; Verheijen RH; Tholander B; Bast RC; Gaarenstroom KN; Sturgeon CM; Bonfrer JM; Petersen PH; Troonen H; CarloTorre G; Kanty Kulpa J; Tuxen MK; Molina R
Int J Gynecol Cancer; 2016 Jan; 26(1):43-51. PubMed ID: 26588231
[TBL] [Abstract][Full Text] [Related]
15. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
16. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
Goff BA; Agnew K; Neradilek MB; Gray HJ; Liao JB; Urban RR
Gynecol Oncol; 2017 Nov; 147(2):291-295. PubMed ID: 28860006
[TBL] [Abstract][Full Text] [Related]
17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
18. CA125 and HE4: Measurement Tools for Ovarian Cancer.
Zhao T; Hu W
Gynecol Obstet Invest; 2016; 81(5):430-5. PubMed ID: 27160726
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
20. An online survey of Irish general practitioner experience of and attitude toward managing problem alcohol use.
Collins C; Finegan P; O'Riordan M
BMC Fam Pract; 2018 Dec; 19(1):200. PubMed ID: 30563475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
